|
|
|
|
|
|
| Return to Savvy Consumer Information Center - Home Page |
![]()
Efficacy rates in this chart are based on Contraceptive Technology (16th edition, 1994). They are yearly estimates of effectiveness in typical use, which refers to a method's reliability in real life, when people don't always use a method properly. For comparison, about 85 percent of sexually active women using no contraception would be expected to become pregnant in a year.
This chart is a summary; it is not intended to be used alone. All product labeling should be followed carefully, and a health-care professional should be consulted for some methods.
Estimated Effectiveness: 88% (a)
Some
Risks (d): Irritation and allergic reactions (less likely with
polyurethane)
Protection from Sexually Transmitted Diseases
(STDs): Except for abstinence, latex condoms are the best
protection against STDs, including herpes and AIDS.
Convenience:
Applied immediately before intercourse; used only once and discarded.
Availability: Nonprescription
Estimated Effectiveness: 79%
Some Risks
(d): Irritation and allergic reactions
Protection
from Sexually Transmitted Diseases (STDs): May give some STD
protection; not as effective as latex condom.
Convenience:
Applied immediately before intercourse; used only once and discarded.
Availability: Nonprescription
Estimated Effectiveness: 82%
Some Risks
(d): Irritation and allergic reactions, urinary tract infection
Protection from Sexually Transmitted Diseases (STDs):
Protects against cervical infection; spermicide may give some protection
against chlamydia and gonorrhea; otherwise unknown.
Convenience:
Inserted before intercourse and left in place at least six hours after;
can be left in place for 24 hours, with additional spermicide for repeated
intercourse.
Availability: Prescription
Estimated Effectiveness: 64-82% (b)
Some
Risks (d): Irritation and allergic reactions, abnormal Pap test
Protection from Sexually Transmitted Diseases (STDs):
Spermicide may give some protection against chlamydia and gonorrhea;
otherwise unknown.
Convenience: May be difficult to
insert; can remain in place for 48 hours without reapplying spermicide for
repeated intercourse.
Availability: Prescription
Estimated Effectiveness: 64-82% (b)
Some
Risks (d): Irritation and allergic reactions, difficulty in
removal
Protection from Sexually Transmitted Diseases
(STDs): Spermicide may give some protection against chlamydia and
gonorrhea; otherwise unknown.
Convenience: Inserted
before intercourse and protects for 24 hours without additional
spermicide; must be left in place for at least six hours after
intercourse; must be removed within 30 hours of insertion; used only once
and discarded.
Availability: Nonprescription; not
currently marketed.
Estimated Effectiveness: 79%
Some Risks
(d): Irritation and allergic reactions
Protection
from Sexually Transmitted Diseases (STDs): May give some
protection against chlamydia and gonorrhea; otherwise unknown.
Convenience: Instructions vary; usually applied no more
than one hour before intercourse and left in place at least six to eight
hours after.
Availability: Nonprescription
Estimated Effectiveness: Over 99% (c)
Some
Risks (d): Dizziness; nausea; changes in menstruation, mood, and
weight; rarely cardiovascular disease, including high blood pressure,
blood clots, heart attack, and strokes
Protection from
Sexually Transmitted Diseases (STDs): None, except some
protection against pelvic inflammatory disease.
Convenience:
Must be taken on daily schedule, regardless of frequency of intercourse.
Availability: Prescription
Estimated Effectiveness: Over 99% (c)
Some
Risks (d): Ectopic pregnancy, irregular bleeding, weight gain,
breast tenderness
Protection from Sexually Transmitted
Diseases (STDs): None, except some protection against pelvic
inflammatory disease.
Convenience: Must be taken on
daily schedule, regardless of frequency of intercourse.
Availability:
Prescription
Estimated Effectiveness: Over 99%
Some
Risks (d): Irregular bleeding, weight gain, breast tenderness,
headaches
Protection from Sexually Transmitted Diseases
(STDs): None
Convenience: One injection
every three months
Availability: Prescription
Estimated Effectiveness: Over 99%
Some
Risks (d): Irregular bleeding, weight gain, breast tenderness,
headaches, difficulty in removal
Protection from Sexually
Transmitted Diseases (STDs): None
Convenience:
Implanted by health-care provider--minor outpatient surgical procedure;
effective for up to five years.
Availability:
Prescription
Estimated Effectiveness: 98-99%
Some
Risks (d): Cramps, bleeding, pelvic inflammatory disease,
infertility, perforation of uterus
Protection from Sexually
Transmitted Diseases (STDs): None
Convenience:
After insertion by physician, can remain in place for up to one or 10
years, depending on type.
Availability:
Prescription
Estimated Effectiveness: About 80% (variable, based on
method)
Some Risks (d): None
Protection
from Sexually Transmitted Diseases (STDs): None
Convenience:
Requires frequent monitoring of body functions (for example, body
temperature for one method).
Availability:
Instructions from health-care provider
Estimated Effectiveness: Over 99%
Some
Risks (d): Pain, bleeding, infection, other minor postsurgical
complications
Protection from Sexually Transmitted Diseases
(STDs): None
Convenience: One-time
surgical procedure
Availability: Surgery
(a) Effectiveness rate for polyurethane condoms has not been established.
(b) Less effective for women who have had a baby because the birth process stretches the vagina and cervix, making it more difficult to achieve a proper fit.
(c) Based on perfect use, when the woman takes the pill every day as directed.
(d) Serious medical risks from contraceptives are rare.
FDA Consumer magazine (April 1997)
| Return to Savvy Consumer Information Center - Home Page |
|
|
|
|
|
|
|
|
|